Development of nitroalkene-based inhibitors to target STING-dependent inflammation.
Chang F, Gunderstofte C, Colussi N, Pitts M, Salvatore SR, Thielke AL, Turell L, Alvarez B, Goldbach-Mansky R, Villacorta L, Holm CK, Schopfer FJ, Hansen AL.
Chang F, et al. Among authors: pitts m.
Redox Biol. 2024 Aug;74:103202. doi: 10.1016/j.redox.2024.103202. Epub 2024 May 21.
Redox Biol. 2024.
PMID: 38865901
Free PMC article.